...
首页> 外文期刊>Advances in Microbiology >Resistance Trends among Pseudomonas aeruginosa Isolates in a Tertiary Care Centre in South Gujarat
【24h】

Resistance Trends among Pseudomonas aeruginosa Isolates in a Tertiary Care Centre in South Gujarat

机译:南古吉拉特邦三级护理中心的铜绿假单胞菌分离株耐药趋势

获取原文
           

摘要

It is necessary to determine the susceptibility pattern of clinical isolates especially nosocomial one in the clinical settings for making strategy for effective empirical treatment & to reduce incidence of multidrug resistant bugs. Aim of this study was to detect the antimicrobial susceptibility pattern of P. aeruginosa isolates from clinical samples between January 2014 to December 2015, received at department of Microbiology, GMC, Surat. Clinical isolates were confirmed as P. aeruginosa by phenotypic methods/Vitek2 compact system as per availability. Genetic sequencing could not be performed due to unavailability. Antimicrobial susceptibility tests were performed by Kirby-Bauer disc diffusion method/Vitek2 compact system & Interpretation was done according Clinical and Laboratory Standards Institute (CLSI) of that year [1] [2]. Seven hundred fifty seven P. aeruginosa strains were studied during the study period. Most of the isolates were from surgery ward (62%), followed by orthopaedic ward (15%). 65% of the total isolates were from swab samples followed by urine (7%), pus, fluid (5%) & devices (4%). 60% isolates were resistant to Ceftazidime & for other drugs resistance pattern was as follows: Cefepime (52%), Levofloxacin (49%), Ticarcillin/clavulanic acid (49%), Meropenem & Gentamycin (44%), Ciprofloxacin (43%), Amikacin (41%), Tobramycin (39%), Netlimycin (36%), Piperacillin (32%), Aztreonam (31%), Piperacillin/tazobactam (26%), Imipenem (23%) , Doripenem (12%) & Gatifloxacin (10%). As there is predominance of isolates from surgical ward in present study & resistance to carbapenem group of drugs was also found, indicating that most of the infection caused by Pseudomonas aeruginosa may be nosocomial.
机译:有必要在临床环境中确定临床分离株尤其是医院分离株的敏感性模式,以制定有效的经验治疗策略并减少多药耐药性虫子的发生。这项研究的目的是检测2014年1月至2015年12月间从苏拉特GMC微生物学部门获得的临床样品中的铜绿假单胞菌分离物的抗菌药敏模式。根据表型方法/ Vitek2紧凑型系统,临床分离株被确认为铜绿假单胞菌。由于不可用,无法进行基因测序。抗菌药敏试验采用Kirby-Bauer纸片扩散法/ Vitek2紧凑型系统进行,并根据当年的临床和实验室标准协会(CLSI)进行解释[1] [2]。在研究期间研究了577个铜绿假单胞菌菌株。大多数分离株来自手术病房(62%),其次是骨科病房(15%)。总分离物的65%来自拭子样品,其次是尿液(7%),脓液,液体(5%)和设备(4%)。 60%的分离株对头孢他啶有耐药性,对其他药物的耐药模式如下:头孢吡肟(52%),左氧氟沙星(49%),替卡西林/克拉维酸(49%),美洛培南和庆大霉素(44%),环丙沙星(43%) ),阿米卡星(41%),妥布霉素(39%),耐特霉素(36%),哌拉西林(32%),阿兹曲南(31%),哌拉西林/他唑巴坦(26%),亚胺培南(23%),多立培南(12%) )和加替沙星(10%)。由于在本研究中主要来自外科病房的分离株,并且还发现了对碳青霉烯类药物的耐药性,表明大多数由铜绿假单胞菌引起的感染可能是医院感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号